Drug intelligence / Profile preview

quinapril + hydrochlorothiazide

Development stage
Phase 1
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Quinapril + hydrochlorothiazide is a fixed-dose combination medication used to treat high blood pressure (hypertension). It contains two active ingredients: - Quinapril, an angiotensin-converting enzyme (ACE) inhibitor that blocks the conversion of angiotensin I to angiotensin II. This leads to relaxation of blood vessels and reduced blood pressure by inhibiting vasoconstriction and decreasing aldosterone-mediated sodium and fluid retention. - Hydrochlorothiazide, a thiazide diuretic ("water pill") that increases urine output by promoting renal excretion of sodium and water. This reduces plasma volume and helps lower blood pressure. The combination provides greater antihypertensive effects than either agent alone. Lowering high blood pressure with this medication reduces the risk of stroke, heart attack, heart failure, kidney failure, and other complications associated with hypertension[1][2][3][4][5][6][8].

Brand names
AccureticQuinaretic
Other names
quinapril/hydrochlorothiazidehydrochlorothiazide and quinaprilHCTZ/quinapril
02

Targets

SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on quinapril + hydrochlorothiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quinapril + hydrochlorothiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call